Maud Marques
Impact in
-
- Epigenetics and DNA Methylation
- Genomics and Chromatin Dynamics
- RNA modifications and cancer
- RNA Research and Splicing
- DNA Repair Mechanisms
- RNA and protein synthesis mechanisms
- Chromatin Remodeling and Cancer
-
- PARP inhibition in cancer therapy
Papers in
-
- RNA modifications and cancer 6
- Genomics and Chromatin Dynamics 5
- Epigenetics and DNA Methylation 4
- RNA and protein synthesis mechanisms 3
- RNA Research and Splicing 2
- Oncology 9
- PARP inhibition in cancer therapy 4
- Colorectal Cancer Treatments and Studies 3
- Co-authors
- Michael Witcher (12 shared papers)Luc Gaudreau (5 shared papers)Liette Laflamme (3 shared papers)Khalid Hilmi (3 shared papers)Tatiana Shorstova (2 shared papers)Tiejun Zhao (4 shared papers)Alain Gervais (2 shared papers)Qiang Sun (3 shared papers)
- Journals
- Nucleic Acids Research (3 papers)BMC Cancer (2 papers)International Journal of Molecular Sciences (2 papers)Cancer Research (2 papers)Molecular Cancer Therapeutics (1 paper)
- Partner nations
- CanadaUnited StatesGermany
In The Last Decade
Maud Marques
24 papers receiving 949 citations
Peers
Comparison fields: 5 of 97
- Molecular Biology 641
- Oncology 191
- Cancer Research 94
- Pharmacology 48
- Reproductive Medicine 41
Countries citing papers authored by Maud Marques
This map shows the geographic impact of Maud Marques's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maud Marques with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maud Marques more than expected).
Fields of papers citing papers by Maud Marques
This network shows the impact of papers produced by Maud Marques. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maud Marques. The network helps show where Maud Marques may publish in the future.
Co-authors
The 25 scholars most cited alongside Maud Marques, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 161 | |
| 2 | 2010 | 87 | |
| 3 | 2017 | 85 | |
| 4 | 2015 | 81 | |
| 5 | 2013 | 70 | |
| 6 | 2017 | 62 | |
| 7 | 2017 | 60 | |
| 8 | 2015 | 59 | |
| 9 | 2019 | 53 | |
| 10 | 2016 | 39 | |
| 11 | 2014 | 38 | |
| 12 | 2014 | 26 | |
| 13 | 2016 | 25 | |
| 14 | 2018 | 25 | |
| 15 | 2019 | 20 | |
| 16 | 2010 | 18 | |
| 17 | 2015 | 16 | |
| 18 | 2019 | 14 | |
| 19 | 2014 | 11 | |
| 20 | 2014 | 3 |
About Maud Marques
Maud Marques is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 26 papers that have together received 959 indexed citations. Recurring topics across this work include RNA modifications and cancer (6 papers), Cancer Genomics and Diagnostics (5 papers), Genomics and Chromatin Dynamics (5 papers), PARP inhibition in cancer therapy (4 papers), Epigenetics and DNA Methylation (4 papers), Colorectal Cancer Treatments and Studies (3 papers), RNA and protein synthesis mechanisms (3 papers) and RNA Research and Splicing (2 papers). The work is most often cited by research in Molecular Biology (641 citations), Oncology (191 citations), Cancer Research (94 citations), Pharmacology (48 citations) and Reproductive Medicine (41 citations). Maud Marques has collaborated with scholars based in Canada, United States and Germany. Frequent co-authors include Michael Witcher, Luc Gaudreau, Liette Laflamme, Khalid Hilmi, Tatiana Shorstova, Tiejun Zhao, Alain Gervais, Qiang Sun, Moulay A. Alaoui‐Jamali and Amine Saad. Their work appears in journals such as Nucleic Acids Research, BMC Cancer, International Journal of Molecular Sciences, Cancer Research and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.